title: H3 or H4 histamine receptors: that which contributes to suppressing human cholangiocarcinoma progression still remains to be clarified.
authors.forename: Gong-Hao
authors.initials: GH
authors.lastname: He
authors.forename: Gui-Li
authors.initials: GL
authors.lastname: Xu
authors.forename: Wen-Ke
authors.initials: WK
authors.lastname: Cai
authors.forename: Wei
authors.initials: W
authors.lastname: Xia
mesh_terms: D000818:Animals; D001650:Bile Duct Neoplasms / Q000188:drug therapy*; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D018281:Cholangiocarcinoma / Q000188:drug therapy*; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists*; D013890:Thiourea / Q000031:analogs & derivatives*
chemical_list: D007093:Imidazoles; D043562:Receptors, G-Protein-Coupled; D013890:Thiourea